344 related articles for article (PubMed ID: 27470662)
1. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.
Pouch SM; Satlin MJ
Virulence; 2017 May; 8(4):391-402. PubMed ID: 27470662
[TBL] [Abstract][Full Text] [Related]
2. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Satlin MJ; Jenkins SG; Walsh TJ
Clin Infect Dis; 2014 May; 58(9):1274-83. PubMed ID: 24463280
[TBL] [Abstract][Full Text] [Related]
3. Carbapenemase-producing Enterobacteriaceae in transplant patients.
Giannella M; Bartoletti M; Conti M; Righi E
J Antimicrob Chemother; 2021 Jan; 76(Suppl 1):i27-i39. PubMed ID: 33534881
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
Mularoni A; Martucci G; Douradinha B; Campanella O; Hazen B; Medaglia A; Arena G; Gruttadauria S; Tuzzolino F; Arcadipane A; Gioè S; Luca A; Conaldi PG; Grossi P; Gridelli B
Transpl Infect Dis; 2019 Aug; 21(4):e13119. PubMed ID: 31112353
[TBL] [Abstract][Full Text] [Related]
5. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
[TBL] [Abstract][Full Text] [Related]
6. [Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
Lübbert C; Hau HM; Rodloff A; Mössner J; Mischnik A; Bercker S; Bartels M; Kaisers UX
Z Gastroenterol; 2015 Nov; 53(11):1276-87. PubMed ID: 26562402
[TBL] [Abstract][Full Text] [Related]
7. Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy.
Johnson K; Boucher HW
Clin Infect Dis; 2014 May; 58(9):1284-6. PubMed ID: 24463279
[No Abstract] [Full Text] [Related]
8. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.
Wong D; Spellberg B
Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821
[TBL] [Abstract][Full Text] [Related]
9. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
[TBL] [Abstract][Full Text] [Related]
11. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
14. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Satlin MJ; Calfee DP; Chen L; Fauntleroy KA; Wilson SJ; Jenkins SG; Feldman EJ; Roboz GJ; Shore TB; Helfgott DC; Soave R; Kreiswirth BN; Walsh TJ
Leuk Lymphoma; 2013 Apr; 54(4):799-806. PubMed ID: 22916826
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Trecarichi EM; Tumbarello M
Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
20. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.
Neuner EA; Gallagher JC
Virulence; 2017 May; 8(4):440-452. PubMed ID: 27589330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
